MESA LABORATORIES INC /CO/ Quarterly Liabilities and Equity in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Mesa Laboratories Inc /Co/ quarterly Liabilities and Equity history and growth rate from Q1 2011 to Q2 2024.
  • Mesa Laboratories Inc /Co/ Liabilities and Equity for the quarter ending June 30, 2024 was $440M, a 31.5% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $440M -$202M -31.5% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $447M -$215M -32.5% Mar 31, 2024 10-Q 2024-08-05
Q4 2023 $742M +$78.8M +11.9% Dec 31, 2023 10-Q 2024-02-05
Q3 2023 $637M -$19M -2.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $643M -$43.2M -6.3% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $662M -$45.5M -6.44% Mar 31, 2023 10-K 2024-06-28
Q4 2022 $663M -$58.7M -8.14% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 $656M +$47.1M +7.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $686M +$73.3M +12% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $707M +$106M +17.6% Mar 31, 2022 10-K 2023-05-30
Q4 2021 $722M +$100M +16.1% Dec 31, 2021 10-Q 2022-02-03
Q3 2021 $609M +$20.2M +3.43% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $612M +$35.8M +6.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $601M +$192M +47% Mar 31, 2021 10-K 2022-05-31
Q4 2020 $622M +$198M +46.8% Dec 31, 2020 10-Q 2021-02-03
Q3 2020 $589M +$196M +50.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $577M +$417M +261% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $409M +$252M +161% Mar 31, 2020 10-K 2021-06-01
Q4 2019 $423M +$265M +168% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $392M +$232M +145% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $160M -$1.79M -1.11% Jun 30, 2019 10-Q 2019-07-30
Q1 2019 $157M -$7.33M -4.47% Mar 31, 2019 10-K 2020-06-01
Q4 2018 $158M -$9.62M -5.73% Dec 31, 2018 10-Q 2019-02-04
Q3 2018 $160M -$13.6M -7.85% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $161M -$7.53M -4.45% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $164M -$7.63M -4.44% Mar 31, 2018 10-K 2019-06-03
Q4 2017 $168M -$2.68M -1.57% Dec 31, 2017 10-Q 2018-02-06
Q3 2017 $174M +$7.68M +4.62% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $169M +$6.92M +4.27% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $172M +$11M +6.83% Mar 31, 2017 10-K 2018-06-05
Q4 2016 $170M +$15.3M +9.89% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 $166M +$10.4M +6.65% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $162M +$44.9M +38.3% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $161M +$43.4M +37% Mar 31, 2016 10-K 2017-06-07
Q4 2015 $155M +$38.9M +33.5% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 $156M +$43.8M +39.1% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $117M +$6.91M +6.26% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $117M +$19.8M +20.3% Mar 31, 2015 10-K 2016-06-06
Q4 2014 $116M +$23.6M +25.5% Dec 31, 2014 10-Q 2015-02-02
Q3 2014 $112M +$46.3M +70.4% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $110M +$46.4M +72.7% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $97.5M +$31.6M +48% Mar 31, 2014 10-K 2015-06-03
Q4 2013 $92.6M +$28.9M +45.5% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $65.8M +$1.35M +2.09% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $63.8M -$2.87M -4.3% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $65.9M +$15.2M +30% Mar 31, 2013 10-K 2014-06-04
Q4 2012 $63.6M +$13.4M +26.7% Dec 31, 2012 10-Q 2013-02-08
Q3 2012 $64.4M +$13.9M +27.5% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $66.7M +$14.5M +27.8% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 $50.7M +$136K +0.27% Mar 31, 2012 10-K 2013-06-06
Q4 2011 $50.2M Dec 31, 2011 10-Q 2012-02-10
Q3 2011 $50.5M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $52.2M Jun 30, 2011 10-Q 2011-08-15
Q1 2011 $50.6M Mar 31, 2011 10-K 2012-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.